Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 30;53(3):565-577.
doi: 10.1042/BST20253041.

Advances in understanding the mechanisms of the human papillomavirus oncoproteins

Denise Ijeoma Obanya  1 , Louisa M Wootton  1 , Ethan L Morgan  1
Affiliations
Review

Advances in understanding the mechanisms of the human papillomavirus oncoproteins

Denise Ijeoma Obanya et al. Biochem Soc Trans. .

Abstract

High-risk human papillomaviruses (HPVs) are responsible for almost all cervical cancer cases and a growing number of oropharyngeal and anogenital cancers. The primary HPV oncoproteins, E6 and E7, act together to manipulate multiple cellular pathways that can ultimately result in malignant transformation. This includes the deregulation of several signalling pathways that regulate cell proliferation, cell cycle progression and cell survival. Although multiple functions of HPV E6 and E7 in driving oncogenesis are well known, recent studies have uncovered novel oncogenic functions of the HPV oncoproteins, including the manipulation of emerging mechanisms of cancer development, such as epigenetic modifications, cellular plasticity and genomic instability. This review explores current advances in understanding how the HPV oncoproteins interact with these cellular processes, highlighting potential therapeutic targets in HPV-associated cancers.

Keywords: E6; E7; HPV; cellular plasticity; epigenetics; genomic instability; ncRNA.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1. Novel interactions of the human papillomaviruses (HPV) oncoproteins with cellular processes involved in HPV-induced oncogenesis.
See this image and copyright information in PMC

References

    1. Vandeven N., Nghiem P. Pathogen-driven cancers and emerging immune therapeutic strategies. Cancer Immunol. Res. 2014;2:9–14. doi: 10.1158/2326-6066.CIR-13-0179. - DOI - PMC - PubMed
    1. Moody C.A. Regulation of the innate immune response during the human papillomavirus life cycle. Viruses. 2022;14:1797. doi: 10.3390/v14081797. - DOI - PMC - PubMed
    1. Buck C.B., Thompson C.D., Pang Y.Y.S., Lowy D.R., Schiller J.T. Maturation of papillomavirus capsids. J. Virol. 2005;79:2839–2846. doi: 10.1128/JVI.79.5.2839-2846.2005. - DOI - PMC - PubMed
    1. Zheng Z.M., Baker C.C. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front. Biosci. 2006;11:2286–2302. doi: 10.2741/1971. - DOI - PMC - PubMed
    1. Doorbar J., Egawa N., Griffin H., Kranjec C., Murakami I. Human papillomavirus molecular biology and disease association. Rev. Med. Virol. 2015;25:2–23. doi: 10.1002/rmv.1822. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources